Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Asset disposition
Class action filed
|
|
Cellectar Biosciences, Inc. (CLRB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 6.6% stake in Cellectar Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Consonance Capital Management LP reports a 0% stake in CELLECTAR BIOSCIENCES INC |
| 02/10/2022 |
SC 13G/A
| Sio Capital Management, LLC reports a 0% stake in Cellectar Biosciences, Inc. |
| 01/21/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 10% stake in Cellectar Biosciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Boxer Capital, LLC reports a 4% stake in Cellectar Biosciences Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| North Sound Trading, LP reports a 4.8% stake in Cellectar Biosciences, Inc. |
| 07/10/2020 |
SC 13G/A
| HIRSCHMAN ORIN reports a 4.3% stake in Cellectar Biosciences, Inc. |
| 02/14/2020 |
SC 13G/A
| Anson Funds Management LP reports a 4.9% stake in Cellectar Biosciences, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| UBS Group AG reports a 5% stake in Cellectar Biosciences, Inc. |
| 02/11/2020 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.5% stake in Cellectar Biosciences, Inc. |
| 02/07/2020 |
SC 13G/A
| North Sound Trading, LP reports a 9.8% stake in Cellectar Biosciences, Inc. |
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 1.5% stake in Cellectar Biosciences, Inc. |
| 01/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/06/2017 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 6.9% stake in Cellectar Biosciences Inc. |
| 06/15/2016 |
SC 13G/A
| Hertzberg Richard has filed a Schedule 13D for CELLECTAR BIOSCIENCES INC |
| 05/10/2016 |
SC 13G/A
| Cellectar Biosciences, Inc. reports a 5.3% stake in CELLECTAR BIOSCIENCES INC |
| 04/12/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|